Kit for detecting versican V1 mRNA in urine and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A
- Publication Date
- 2020-06-05
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medical detection, in particular to a kit for detecting versican V1 mRNA in urine and its application in the prognosis diagnosis of focal segmental glomerulosclerosis. Background technique
[0002] Focal Segmental Glomerular Sclerosis (FSGS) is a typical podocyte disease. Most of the patients have non-selective proteinuria, and hypertension and renal dysfunction are more common at the onset, often accompanied by renal tubular dysfunction. Pathologically, focal segmental lesions of glomeruli and acute and chronic lesions of tubulointerstitium can be seen in patients with FSGS. Although FSGS and minimal change disease (MCD) belong to the same podocyte disease, the clinicopathological damage is more severe than that of MCD, and the long-term prognosis is worse than that of MCD. The degree of chronic tubulointerstitial disease is closely related to the prognosis of FSGS. It is of great practical significance to find...